It's not hard to understand why billionaires were after dividend-paying stocks. It's a well-established fact that they outperform shares of companies that aren't committed to delivering a portion of their profits to shareholders. During the 50-year period that ended in 2022, shares of dividend payers in the S&P 500 index delivered a 9.2% average annual return. Over the same time frame, non-dividend payers actually fell by 0.6% per year on average. It stands to reason that the dividend stocks the world's most successful investors pick are likely to outperform. That said, everyone makes mistakes from time to time. Let's take a closer look at two stocks billionaires can't get enough of to see if they deserve a place in your portfolio too.
Many income-seeking investors have been avoiding AT&T (T) stock because they remember how the company slashed its payout by 47% last year. What you might not realize is that the business has been through a major overhaul that should make future growth far more predictable. Pfizer (PFE) gained a lot of fame for rapidly developing a COVID-19 vaccine and an antiviral treatment that generated a combined $56.7 billion in sales last year.
Source: Motley Fool
Related Articles:
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.